Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies
G Patel, S Huprikar, SH Factor, SG Jenkins… - Infection Control & …, 2008 - cambridge.org
Background.Carbapenem-resistant Klebsiella pneumoniae is an emerging healthcare-associated
pathogen.Objective.To describe the epidemiology of and clinical outcomes associated …
pathogen.Objective.To describe the epidemiology of and clinical outcomes associated …
[HTML][HTML] “Stormy waters ahead”: global emergence of carbapenemases
G Patel, R Bonomo - Frontiers in microbiology, 2013 - frontiersin.org
Carbapenems, once considered the last line of defense against of serious infections with
Enterobacteriaceae, are threatened with extinction. The increasing isolation of carbapenem-…
Enterobacteriaceae, are threatened with extinction. The increasing isolation of carbapenem-…
Introductions and early spread of SARS-CoV-2 in the New York City area
New York City (NYC) has emerged as one of the epicenters of the current severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To identify the early transmission …
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To identify the early transmission …
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study
…, GM Lyon, LE Bell, S Huprikar, G Patel… - The Lancet infectious …, 2010 - thelancet.com
Background There are few data on the epidemiology and outcomes of influenza infection in
recipients of solid-organ transplants. We aimed to establish the outcomes of pandemic …
recipients of solid-organ transplants. We aimed to establish the outcomes of pandemic …
[HTML][HTML] Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants
…, H Alshammary, S Schaefer, G Patel… - Nature …, 2023 - nature.com
Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have
been reported in immune-compromised individuals and people undergoing immune-…
been reported in immune-compromised individuals and people undergoing immune-…
[HTML][HTML] Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study
…, M Mansour, E Leven, NM Bouvier, G Patel… - The Lancet …, 2020 - thelancet.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
global pandemic. The proportion of infected individuals who seroconvert is still an open …
global pandemic. The proportion of infected individuals who seroconvert is still an open …
Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United …
Although the New York/New Jersey (NY/NJ) area is an epicenter for carbapenem-resistant
Enterobacteriaceae (CRE), there are few multicenter studies of CRE from this region. We …
Enterobacteriaceae (CRE), there are few multicenter studies of CRE from this region. We …
Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity
…, S Sharma, SP Blash, G Patel… - Infection Control & …, 2013 - cambridge.org
Objective.To describe the epidemiology of carbapenem-resistant Enterobacteriaceae (CRE)
carriage and acquisition among hospitalized patients in an area of CRE endemicity.Design.…
carriage and acquisition among hospitalized patients in an area of CRE endemicity.Design.…
In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
A Endimiani, G Patel, KM Hujer… - Antimicrobial agents …, 2010 - Am Soc Microbiol
In vitro activity of fosfomycin was evaluated against 68 bla KPC -possessing Klebsiella
pneumoniae (KpKPC) isolates, including 23 tigecycline- and/or colistin-nonsusceptible strains. By …
pneumoniae (KpKPC) isolates, including 23 tigecycline- and/or colistin-nonsusceptible strains. By …
Status report on carbapenemases: challenges and prospects
G Patel, RA Bonomo - Expert review of anti-infective therapy, 2011 - Taylor & Francis
Antimicrobial resistance in hospital and community-onset bacterial infections is a significant
source of patient morbidity and mortality. In the past decade, we have witnessed the …
source of patient morbidity and mortality. In the past decade, we have witnessed the …